Introduction
One early transmembrane signal in response to stimulation of the T-cell antigen receptor (CD 3/Ti) is the activation of phosphatidylinositol (Ptd1ns)-specific phospholipase C (PLC). The resulting formation of inositol 1, 4, 4, 5) q?) and diacylglycerol (DAG) causes calcium release from internal stores, calcium influx through calcium channels, and translocation of protein kinase C (PKC) to the plasma membrane (for a review, see [l] ). Although this signal is associated with T-cell responses, several studies have shown that PLC activation can occur without resulting in cellular proliferation. For example, when immobilized anti-CD3 monoclonal antibodies (mAbs) are used for stimulation of T-cells, the PLC activation signal is prolonged and results in interleukin 2 (IL-2) receptor a-chain (CD25) expression, production of cytokines including IL-2 and T-cell autocrine proliferation [2, 31. In contrast, when anti-CD3 mAbs are used in solution, the PLC activation signal is transient and does not result in T-cell autocrine proliferation. Rather, desensitization occurs, resulting in a period of non-responsiveness to stimulation of other receptors [4] .
Transient activation of PLC also occurs in T-cells when other receptors such as CD2, CD5 or CD28 are cross-linked on the cell surface with specific mAbs [5] . These molecules have been implicated as receptors for accessory signals in T-cell activation, since mAb-mediated ligation can augment responses to CD3/Ti stimulation [6] . The CD2 and CD28 receptors are known to mediate cell-cell adhesion with antigen-presenting cells by binding to their co-receptors, the LFA-3 and the B7/BB1 molecules, respectively [7, and the B7/BB1 deliver transmembrane signals to T-cells through the CD2 or CD28 molecules [9, 101. A normal ligand for CD5, however, has not yet been identified. All of these accessory receptors that activate PLC depend upon expression of CD3/Ti for their functional activity [4] .
How are these T-cell surface receptors coupled to activation of PLC in the plasma membrane? Several studies have implicated GTPAbbreviations used: PLC, phospholipase C; mAbs, monoclonal antibodies; IL-2, interleukin-2.
binding G-proteins in the process, because non-hydrolysable GTP analogues or fluoroaluminate activate PLC either in T-cells or in T-cell membrane fractions (see [l] for a review). Additional evidence derives from experiments where CD 3/Ti-negative Jurkat T-cells were transfected with one subtype of the muscarinic acetylcholine receptor, resulting in PLC activation and IL-2 secretion after stimulation with carbachol [ 1 11.
Because the muscarinic acetylcholine receptor is a G-protein-linked receptor, these studies indicate that T-cells contain G-protein(s) that can activate PLC, and that a PLC exists in T-cells that can be regulated by G-proteins. These data, however, do not show that the endogenous surface receptors linked to PLC activation in T-cells use this mechanism.
A second early transmembrane signal associated with stimulation of CD3/Ti is the rapid induction of tyrosine phosphorylation of specific substrates In this communication, we address the PLC activation signals induced in T-cells by cross-linking accessory receptors including CD2, CD28 and CD4. In each case, tyrosine phosphorylation is required for PLC activation, although differential sensitivity to inhibition by herbimycin A is shown. Evidence for the regulation of protein-tyrosine kinase activation by stimulation of these receptors, obtained by anti-phosphotyrosine immunoblotting of whole cell lysates, is also presented.
Results and discussion
Measurement of cytoplasmic calcium concentration ([Ca'+];) with the indo-1 dye and a flow cytometer provides a very sensitive assay for the activation of PLC in T-cells [18] . To activate PLC by CD2, CD28 or CD4 receptor ligation, we used biotinconjugated mAbs followed by an excess of avidin ( Fig. 1) . In this experiment, the signal from CD2 cross-linking was very strong, reaching a peak of
within 3 min of avidin addition. This response is a combination of intracellular calcium release and extracellular calcium influx [19] . The signal from the interaction of the CD3 and CD4 receptors, generated by cross-linking CD3 and CD4 together with an antibody hetero- Cells were stimulated with ionomycin, CD2 cross-linking with biotin-9.6, followed by avidin added at the arrow; CD3 X CD4 cross-linking with 5 p g of a heteroconjugate of mAbs G I9-4 X G 17-2, CD3 cross-linking with an IgM anti-CD3 mAb 38. I; CD28 cross-linking with biotin-9.3 followed by avidin added at the arrow; or CD4 cross-linking with biotin-(; 17-2 followed by avidin added at the arrow. The CD28 and CD4 receptors also generated signals when cross-linked, and these were smaller, but significant and reproducible [S] . Like CD2, the CD3, CD3 X CD4, CD28 and CD4 signals are initiated by intracellular calcium release followed by extracellular calcium influx [S].
The resting T-cells incubated with 1 pg of Herbimycin A/ml were still viable and were able to respond to ionomycin (Fig. 1) . However, the 
Tyrosine phosphotylation of substrates in HPB-ALL T-cells is regulated by the C D W i and CD4 receptors
HBP-ALL cells were stimulated with a CD3XCD3 homoconjugate of mAb G 19-4 (10 pg/ml), a CD3 X CD4 heteroconjugate of mAbs G 19-4 X G 17-2 ( I0 pg/ml), or a CD4 X CD4 homoconjugate of mAb G17-2 (10 pg/ml). At 0 (before stimulation), 2 and 10 min after stimulation, 5 X lo6 cells were rapidly pelleted and lysed in SM sample buffer. Polyacrylamide gels were run and protein was transferred to a PVDF filter. Tyrosine-phosphorylated proteins were detected by immunoblotting with purified rabbit anti-phosphotyrosine followed by 1251-labelled protein A. Molecular mass markers were included and their migration positions are indicated. 
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Table I Effect of Herbimycin A on calcium mobilization in resting T-cells
Peripheral blood mononuclear cells (containing 8040% T-cells) were isolated by centrifugation on Ficoll and were then incubated at 106 cell/ml in RPMl with 5% (v/v) fetal bovine serum for 16 h in the indicated concentrations of herbimycin A. Stimulation of the cells was with IgM anti-CD3 mAb 38.1 (CD3) at an optimal concentration, by cross-linking CD2 using biotin-conjugated mAb 9.6 followed by avidin (CD2), or by a heteroconjugate of anti-CD3 X anti-CD4 mAbs G I 9 4 and G 17-2 at 5 pg/ml (CD3 X CD4 responses to receptor cross-linking were almost completely absent.
To examine the comparative sensitivity of these signals to Herbimycin A, a titration between 0.125 ,ug/ml and 1 pg/ml was used for the 16 h incubation. The CD3, CD2 and CD3XCD4 signals were then compared at each Herbimycin concentration (Table 1 ). A significant difference was readily apparent, since the CD 3-induced signal was completely inhibited by 0.5 ,ug/ml, whereas the CD2 and CD3 X CDCinduced signals were only partially inhibited. In this experiment, the CD2 and CD3 X CD4 signals were still present even at 1 pg of Herbimycin A/ml. These results suggest that the accessory receptors on T-cells that are linked to PLC activation are not equally dependent on protein-tyrosine kinase activity, and that the strongest signals are more resistant to inhibitors of protein-tyrosine kinases.
Multiple isoenzymes of PLC have been characterized [20] . Although T-cells may contain a form such as PLCS that is activated by a G-protein mechanism, it is clear that the CD3/Ti receptorlinked PLC must be closely related to PLCy because the activity of this isoenzyme is directly regulated by tyrosine phosphorylation [21] . Our evidence suggests that the CD2, CD4, CD28 and other accessory receptors that are linked to PLC activation are also dependent upon first initiating protein-tyrosine kinase activation. Consistent with this idea are the observations that CD2 cross-linking induces tyrosine phosphorylation in T-cells
[22], and that the CD4 and CD8 receptors are noncovalently associated with the protein-tyrosine kinase ~5 6~~
[23]. Association of the CD4 or CD8 receptor with CD 3/Ti enhances the activation of PLC [24] , whereas similar CD3/Ti interaction with the CD45 protein-tyrosine phosphatase inhibits both the [Ca2+Ii response and the activation of PLC Cross-linking of CD4 was shown to activate the associated ~5 6 ' "~ protein-tyrosine kinase and to induce tyrosine phosphorylation of specific cellular substrates [26] . Because the CD4 interaction with CD3/Ti results in enhanced PLC activation, we examined the effects of this interaction on induction of tyrosine phosphorylation. Fig. 2 shows that, in comparison with either CD4 or CD3/Ti cross-linking separately, the cross-linking of CD3 and CD4 together results in a much stronger signal. Tyrosine-phosphorylated proteins are detectable at 20 kDa, 35 kDa, 55 kDa, 67 kDa, 80 kDa, 105 kDa and 150 kDa in the HPB-ALL T-cells used for this experiment and are similar to the tyrosine-phosphorylated proteins seen in normal T-cells, Jurkat T-cells or CEM T-cells. PLC or regulators of PLC are likely to be included among these substrates of tyrosine kinases in T-cells.
Introduction
Interleukin 4 (IL-4) is a T-cell-derived lymphokine with pleiotropic effects on many different cell types (reviewed in [ 11). One of the first activities ascribed to this factor was its capacity to act as a co-mitogen in B-lymphocytes, in conjunction with submitogenic concentrations of antibodies (anti-Ig) directed to the clonally distributed surface immunoglobulin receptors (sIgM and sIgD) on these cells. Ligation of sIg receptors provokes the hydrolysis of phosphatidylinositol 4,s-bisphosphate [PtdIns (4, 5) shown to induce a short-lived burst of Ins( 1,4,5)P3 release, followed by a prolonged elevation of cyclic
